Carcinoma, Acinar Cell: Clinical Trials

4 trials for Carcinoma, Acinar Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 recruiting, 1 terminated. 2 Phase 1, 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Terminated 1
Phase 22Active not recruiting 1, Recruiting 1
Not applicable1Active not recruiting 1

Follow Carcinoma, Acinar Cell: new trials by email Literature Review of Carcinoma, Acinar Cell trials Research Report on Carcinoma, Acinar Cell

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ART0380, Gemcitabine, Irinotecan - Advanced Cancer, Metastatic Cancer
Phase 1 / Phase 2RecruitingArtios Pharma Ltd5422021-01-272026-10-22
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
P-PSMA-101 CAR-T cells, Rimiducid - Prostatic Neoplasms, Castration-Resistant, Neoplasms by Histologic Type
Phase 1TerminatedPoseida Therapeutics, Inc.402020-02-282025-02-17
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)7982017-01-302026-06-17
WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer
Pancreatectomy, Lavage - Acinar Cell Carcinoma, Ampulla of Vater Adenocarcinoma
Not applicableActive not recruitingSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University8452016-04-272026-05-29

Narrower conditions

Carcinoma, Adenoid Cystic (2)  ·  Cholangiocarcinoma (2)  ·  Adenocarcinoma, Bronchiolo-Alveolar (1)  ·  Adenocarcinoma, Mucinous (1)  ·  Adrenocortical Carcinoma (1)  ·  Bile Duct Neoplasms (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Endometrioid (1)  ·  Carcinoma, Giant Cell (1)  ·  Carcinoma, Mucoepidermoid (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)  ·  Chordoma (1)  ·  Colorectal Neoplasms (1)

Broader conditions

Adenocarcinoma (4)  ·  Carcinoma (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Urogenital Diseases (3)  ·  Adnexal Diseases (2)

Interventions

CTLA-4 Antigen (1)  ·  Gemcitabine (1)  ·  Ipilimumab (1)  ·  Irinotecan (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nivolumab (1)  ·  Pancreatectomy (1)  ·  Specimen Handling (1)  ·  Therapeutic Irrigation (1)

Sponsors

Artios Pharma Ltd (1)  ·  National Cancer Institute (NCI) (1)  ·  Poseida Therapeutics, Inc. (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

United States (4)  ·  France (1)  ·  Guam (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Antonio Gonzalez, MD, PHD (1)  ·  Harish Lavu, MD (1)  ·  Kim Reiss Binder, MD (1)  ·  Melissa Johnson, MD (1)  ·  Rajesh Belani, M.D. (1)  ·  Sandip P Patel (1)  ·  Susanna Ulahannan, MD (1)

Results publications

PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790

NIH funding

U10CA180888 (1)